MedTech Acquisition Corporation Unit
MTACU
MTACU was delisted on the 10th of August, 2023.
5 hedge funds and large institutions have $474K invested in MedTech Acquisition Corporation Unit in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.
55% less funds holding
Funds holding: 11 → 5 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
99% less capital invested
Capital invested by funds: $40.7M → $474K (-$40.2M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
+$46.7K |
| 2 |
DM
Deerfield Management
New York
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.5M |
| 2 |
MP
MSD Partners
New York
|
-$12M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$3.11M |
| 4 |
BCL
Bracebridge Capital LLC
Boston,
Massachusetts
|
-$2.98M |
| 5 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
-$2.01M |
MTACU Hedge Fund Activity: Q1 2022 in Review
5 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q1 2022, worth a combined $474K — down 99% from $40.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MTACU and 2 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Integrity Capital Management (HK), opening a new position worth an estimated $46.7K. The largest seller was Wellington Management Group, exiting entirely with an estimated $18.5M sold.
- 5 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q1 2022, down from 11 in Q4 2021.
- Funds reported $474K of MedTech Acquisition Corporation Unit stock for Q1 2022, down 99% quarter-over-quarter.
- 2 funds opened new MedTech Acquisition Corporation Unit positions in Q1 2022 and 8 closed out, a net change of -6 holders.
- The largest MedTech Acquisition Corporation Unit buyer in Q1 2022 was Integrity Capital Management (HK), an estimated $46.7K added.
- The largest MedTech Acquisition Corporation Unit seller in Q1 2022 was Wellington Management Group, an estimated $18.5M sold.
Based on aggregated 13F filings for Q1 2022.